Axel Finckh
Axel Finckh publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments.
- World rank
- #191,396 of 7,710,434 ranked researchers
- Rank in Switzerland
- #3,841 of 80,918
- Works
- 428
- Citations
- 25k
- Citations per work
- 58.8
What does Axel Finckh research?
Axel Finckh's work is mostly in Medicine (58%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences24958.1%
- Medicine24958.1%
- Everything else14333.5%
- Life Sciences368.4%
- 1Rheumatology42% of their works
- 2Immunology8% of their works
- 3Hematology5% of their works
- 4Pathology and Forensic Medicine5% of their works
- 5Genetics3% of their works
- 6Surgery3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Biosimilars and Bioanalytical Methods
- Chronic Lymphocytic Leukemia Research
- Monoclonal and Polyclonal Antibodies Research
- Lymphoma Diagnosis and Treatment
Which keywords describe Axel Finckh's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Ankylosing Spondylitis, Spondyloarthritis and Monoclonal Antibodies.
- Classification
- Fc Receptors
- Chronic Lymphocytic Leukemia
- Biosimilars
- Hemophagocytic Lymphohistiocytosis
- Monoclonal Antibodies
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Spondyloarthritis
- Rituximab
- Juvenile Idiopathic Arthritis
- Immunogenicity
- Genomic Aberrations
- Therapeutic Antibodies
- Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies3872 topics
- Inflammation2961 topic
- Rheumatoid Arthritis2961 topic
- Antiphospholipid Syndrome911 topic
- Systemic Lupus Erythematosus911 topic
- Ankylosing Spondylitis831 topic
- Spondyloarthritis831 topic
- Monoclonal Antibodies782 topics
- Rituximab572 topics
- Hemophagocytic Lymphohistiocytosis531 topic
- Juvenile Idiopathic Arthritis531 topic
- Biosimilars521 topic
- Immunogenicity521 topic
- Chronic Lymphocytic Leukemia341 topic
- Genomic Aberrations341 topic
- Fc Receptors261 topic
- Therapeutic Antibodies261 topic
- Classification231 topic
- Lymphoma231 topic
Where does Axel Finckh work?
Axel Finckh's main affiliation in the publication record is University Hospital of Geneva, Switzerland.
How many publications and citations does Axel Finckh have?
OpenAlex counts 428 works and 25,158 citations for Axel Finckh, an h-index of 65, ranking #191,396 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Axel Finckh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.